The pens are part of an initiative to “fundamentally lower health care costs, not spread” them, Gov. Gavin Newsom said.

California will begin selling affordable insulin under its own label on Jan. 1, nearly three years after he first announced a partnership to sell state-branded generic drugs at lower prices.